{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:21:47Z","timestamp":1784784107236,"version":"3.55.0"},"reference-count":42,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cedars-Sinai Medical Center"},{"name":"reast research grants from Armando Giuliano"},{"name":"Fashion Footwear Charitable Foundation of New York, Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Fibroepithelial lesions of the breast (FELs) are a heterogeneous group of neoplasms exhibiting a histologic spectrum ranging from fibroadenomas (FAs) to malignant phyllodes tumors (PTs). Despite published histologic criteria for their classification, it is common for such lesions to exhibit overlapping features, leading to subjective interpretation and interobserver disagreements in histologic diagnosis. Therefore, there is a need for a more objective diagnostic modality to aid in the accurate classification of these lesions and to guide appropriate clinical management. In this study, the expression of 750 tumor-related genes was measured in a cohort of 34 FELs (5 FAs, 9 cellular FAs, 9 benign PTs, 7 borderline PTs, and 4 malignant PTs). Differentially expressed gene analysis, gene set analysis, pathway analysis, and cell type analysis were performed. Genes involved in matrix remodeling and metastasis (e.g., MMP9, SPP1, COL11A1), angiogenesis (VEGFA, ITGAV, NFIL3, FDFR1, CCND2), hypoxia (ENO1, HK1, CYBB, HK2), metabolic stress (e.g., UBE2C, CDKN2A, FBP1), cell proliferation (e.g., CENPF, CCNB1), and the PI3K-Akt pathway (e.g., ITGB3, NRAS) were highly expressed in malignant PTs and less expressed in borderline PTs, benign PTs, cellular FAs, and FAs. The overall gene expression profiles of benign PTs, cellular FAs, and FAs were very similar. Although a slight difference was observed between borderline and benign PTs, a higher degree of difference was observed between borderline and malignant PTs. Additionally, the macrophage cell abundance scores and CCL5 were significantly higher in malignant PTs compared with all other groups. Our results suggest that the gene-expression-profiling-based approach could lead to further stratification of FELs and may provide clinically useful biological and pathophysiological information to improve the existing histologic diagnostic algorithm.<\/jats:p>","DOI":"10.3390\/ijms24109041","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T03:57:32Z","timestamp":1684727852000},"page":"9041","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Gene Expression Profiling of Fibroepithelial Lesions of the Breast"],"prefix":"10.3390","volume":"24","author":[{"given":"Xiaomo","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6578-178X","authenticated-orcid":false,"given":"Eric","family":"Vail","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"Maluf","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manita","family":"Chaum","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Leong","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Lownik","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingtian","family":"Che","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Giuliano","sequence":"additional","affiliation":[{"name":"Saul and Joyce Brandman Breast Center, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duoyao","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Dadmanesh","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"key":"ref_1","unstructured":"(2022, June 21). IARC Publications Website\u2014Breast Tumours. Available online: https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/Breast-Tumours-2019."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/1066896914548763","article-title":"Interobserver Variability by Pathologists in the Distinction Between Cellular Fibroadenomas and Phyllodes Tumors","volume":"22","author":"Lawton","year":"2014","journal-title":"Int. J. Surg. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1053\/j.semdp.2017.05.006","article-title":"Fibroepithelial lesions, The WHO spectrum","volume":"34","author":"Krings","year":"2017","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_4","first-page":"492","article-title":"Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: A retrospective analysis of 192 cases at a single center","volume":"33","author":"Wei","year":"2014","journal-title":"Chin. J. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s10517-020-04985-5","article-title":"Prognostic Molecular and Biological Characteristics of Phyllodes Tumors of the Breast","volume":"169","author":"Vorotnikov","year":"2020","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/jclinpath-2011-200368","article-title":"Predicting clinical behaviour of breast phyllodes tumours: A nomogram based on histological criteria and surgical margins","volume":"65","author":"Tan","year":"2012","journal-title":"J. Clin. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00268-020-05385-6","article-title":"Fibroepithelial Lesions (FELs) of the Breast: Is Routine Excision Always Necessary?","volume":"44","author":"Limberg","year":"2020","journal-title":"World J. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.18632\/oncotarget.27889","article-title":"Quantitative proteome profiling stratifies fibroepithelial lesions of the breast","volume":"12","author":"Kumar","year":"2021","journal-title":"Oncotarget"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41523-020-0169-8","article-title":"Histopathologic, immunophenotypic, and proteomics characteristics of low-grade phyllodes tumor and fibroadenoma: More similarities than differences","volume":"6","author":"Zhang","year":"2020","journal-title":"NPJ Breast Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10549-010-1204-5","article-title":"Molecular classification of breast phyllodes tumors: Validation of the histologic grading scheme and insights into malignant progression","volume":"129","author":"Ang","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/(SICI)1097-0142(19960301)77:5<910::AID-CNCR16>3.0.CO;2-6","article-title":"The treatment and prognosis of patients with phyllodes tumor of the breast: An analysis of 170 cases","volume":"77","author":"Reinfuss","year":"1996","journal-title":"Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/modpathol.3800488","article-title":"P53 and c-kit (CD117) protein expression as prog-nostic indicators in breast phyllodes tumors: A tissue microarray study","volume":"18","author":"Tan","year":"2005","journal-title":"Modern Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4103\/JLP.JLP_106_19","article-title":"Immunohistochemical expression of Ki-67, p53, and CD10 in phyllodes tumor and their correlation with its histological grade","volume":"11","author":"Shubham","year":"2019","journal-title":"J. Lab. Physicians"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/PAI.0b013e3181f5349a","article-title":"Immunohistochemical and Molecular Markers in Breast Phyllodes Tumors","volume":"19","author":"Korcheva","year":"2011","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_15","unstructured":"Early, C., Lotfalla, M., White, M., Oh, E.Y., Matoso, A., and Argani, P. (2022). ERG Labeling in Malignant Phyllodes Tumors: A Potential Diagnostic Pitfall, USCAP."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cdip.2005.08.007","article-title":"Recent advances in the pathology of fibroepithelial tumours of the breast","volume":"11","author":"Tse","year":"2005","journal-title":"Curr. Diagn. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/jclinpath-2017-204838","article-title":"Genetics and genomics of breast fibroadenomas","volume":"71","author":"Loke","year":"2018","journal-title":"J. Clin. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41379-021-00787-w","article-title":"Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing","volume":"34","author":"Ng","year":"2021","journal-title":"Mod. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.molonc.2015.01.003","article-title":"Gene expression-based classifications of fibroadenomas and phyllodes tumours of the breast","volume":"9","author":"Vidal","year":"2015","journal-title":"Mol. Oncol."},{"key":"ref_20","unstructured":"Zhang, Y., and Kleer, C.G. (2016). Archives of Pathology and Laboratory Medicine, College of American Pathologists."},{"key":"ref_21","first-page":"159","article-title":"Breast fibroadenomas in adolescents: Current perspectives","volume":"6","author":"Soltanian","year":"2015","journal-title":"Adolesc. Heal Med. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21037\/abs-20-99","article-title":"Diagnosis and management of phyllodes tumors of the breast","volume":"5","author":"Simpson","year":"2021","journal-title":"Ann. Breast Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1503\/cjs.017617","article-title":"Surgical management of benign phyllodes tumours of the breast: Is wide local excision really necessary?","volume":"61","author":"Qian","year":"2018","journal-title":"Canad. J. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Hench, J., Vlajnic, T., Soysal, S.D., Obermann, E.C., Frank, S., and Muenst, S. (2022). An Integrated Epigenomic and Genomic View on Phyllodes and Phyllodes-like Breast Tumors. Cancers, 14.","DOI":"10.3390\/cancers14030667"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Alatan, H., Chen, Y., Zhou, J., and Wang, L. (2021). Extracellular Matrix-Related Hubs Genes Have Adverse Effects on Gastric Adeno-carcinoma Prognosis Based on Bioinformatics Analysis. Genes, 12.","DOI":"10.3390\/genes12071104"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"BSR20211615","DOI":"10.1042\/BSR20211615","article-title":"Identification of potential genes related to breast cancer brain metastasis in breast cancer patients","volume":"41","author":"Zhang","year":"2021","journal-title":"Biosci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.juro.2015.11.050","article-title":"Expression of Genes Involved in Cellular Adhesion and Extracellular Matrix Remodeling Correlates with Poor Survival of Patients with Renal Cancer","volume":"195","author":"Boguslawska","year":"2016","journal-title":"J. Urol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e11145","DOI":"10.7717\/peerj.11145","article-title":"COL1A1 is a prognostic biomarker and correlated with immune infiltrates in lung cancer","volume":"9","author":"Geng","year":"2021","journal-title":"PeerJ"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1083\/jcb.201102147","article-title":"The extracellular matrix: A dynamic niche in cancer progression","volume":"196","author":"Lu","year":"2012","journal-title":"J. Cell Biol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Huang, H. (2018). Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances. Sensors, 18.","DOI":"10.3390\/s18103249"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"112153","DOI":"10.1016\/j.yexcr.2020.112153","article-title":"Microenvironment remodeled by tumor and stromal cells elevates fi-broblast-derived COL1A1 and facilitates ovarian cancer metastasis","volume":"394","author":"Li","year":"2020","journal-title":"Exp. Cell Res."},{"key":"ref_32","first-page":"E2900","article-title":"VEGF-B promotes cancer metastasis through a VEGF-A\u2013independent mechanism and serves as a marker of poor prognosis for cancer patients","volume":"112","author":"Yang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","first-page":"1","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/B978-0-12-381298-8.00027-7","article-title":"Measurement of Constitutive MAPK and PI3K\/AKT Signaling Activity in Human Cancer Cell Lines","volume":"484","author":"Paraiso","year":"2010","journal-title":"Methods Enzymol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"22231","DOI":"10.1073\/pnas.1015245107","article-title":"Inositol polyphosphate 4-phosphatase II regulates PI3K\/Akt signaling and is lost in human basal-like breast cancers","volume":"107","author":"Fedele","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/his.13782","article-title":"Expression of biomarkers in the AKT pathway correlates with malignancy and recurrence in phyllodes tumours of the breast","volume":"74","author":"Li","year":"2018","journal-title":"Histopathology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"566511","DOI":"10.3389\/fonc.2020.566511","article-title":"Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers","volume":"10","author":"Larionova","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-015-0621-0","article-title":"Human breast cancer cells educate macrophages toward the M2 activation status","volume":"17","author":"Sousa","year":"2015","journal-title":"Breast Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3892\/ijo.2014.2794","article-title":"CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma","volume":"46","author":"Meng","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1158\/0008-5472.CAN-16-2709","article-title":"Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation","volume":"77","author":"Nie","year":"2017","journal-title":"Cancer Res"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Munir, M.T., Kay, M.K., Kang, M.H., Rahman, M., Al-Harrasi, A., Choudhury, M., Moustaid-Moussa, N., Hussain, F., and Rahman, S.M. (2021). Tumor-Associated Macrophages as Multifaceted Regulators of Breast Tumor Growth. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126526"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1158\/1078-0432.CCR-18-3421","article-title":"Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy","volume":"25","author":"Nie","year":"2019","journal-title":"Clin. Cancer Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/10\/9041\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:39:03Z","timestamp":1760125143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/10\/9041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,20]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["ijms24109041"],"URL":"https:\/\/doi.org\/10.3390\/ijms24109041","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,20]]}}}